MedPath

Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease

Recruiting
Conditions
Chronic Hepatitis B
Nonalcoholic Fatty Liver Disease
Registration Number
NCT02863757
Lead Sponsor
Humanity and Health Research Centre
Brief Summary

The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1500
Inclusion Criteria
  • Liver biopsy proved CHB and/or NAFLD at baseline;
  • Chinese
  • Follow-up duration>12 months
Exclusion Criteria
  • Other liver diseases;
  • Secondary causes of hepatic steatosis;
  • Alcohol abuse;
  • Liver cirrhosis, cirrhosis related complications or HCC at baseline;
  • Malignancy;
  • History of liver transplantation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of patients with liver cirrhosis, hepatic encephalopathy, esophageal varices, ascites and hepatocellular carcinomaUp to 20 years
Secondary Outcome Measures
NameTimeMethod
Number of patients with liver transplantation and liver-related deathUp to 20 years
Number of patients with hypertension, obesity, diabetes mellitus, hyperlipidaemiaUp to 20 years
Diagnosis time of liver cirrhosis, hepatic encephalopathy, esophageal varices, ascites and hepatocellular carcinoma from baselineUp to 20 years
Occurrence time of liver transplantation and liver-related death from baselineUp to 20 years

Trial Locations

Locations (1)

Humanity and Health GI and Liver Centre

🇨🇳

Hong Kong, Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath